Bio-Rad Laboratories Analysts Raise Their Forecasts After Better-Than-Expected Q2 Earnings Bio-Rad Laboratories, Inc. (NYSE:BIO) reported better-than-expected second-quarter financial results on Thursday. Benzinga · Aug 1, 2025
Bio-Rad Laboratories Stock: Is BIO Underperforming the Healthcare Sector? Despite Bio-Rad Laboratories’ underperformance relative to the healthcare sector over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects. Barchart · Sep 30, 2024
What You Need to Know Ahead of Bio-Rad Laboratories' Earnings Release Bio-Rad Laboratories is expected to release its fiscal second-quarter earnings next month, and analysts project a double-digit profit dip. Barchart · Jul 19, 2024
Why Is Super Micro Computer Higher By More Than 13%? 42 Stocks Moving In Thursday's Mid-Day Session Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) shares jumped 364.3% to $23.22. The company offered shares at an expected price of $5.00 per share with an insider lock-up period of 180 days ending on January 17, 2023. Benzinga · Jul 21, 2022
5 Value Stocks To Watch In The Healthcare Sector What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock. Benzinga · May 2, 2022
Recap: Bio-Rad Laboratories Q1 Earnings Bio-Rad Laboratories (NYSE:BIO) reported its Q1 earnings results on Thursday, April 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Benzinga · Apr 28, 2022